Home › Condizioni post-COVID (Long COVID) › Illinois › Chicago
Studi clinici su Condizioni post-COVID (Long COVID) a Chicago, IL
11 studi su Condizioni post-COVID (Long COVID) cercano partecipanti presso sedi a Chicago e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
In reclutamentoFase 3
- Rush University Medical Center ( Site 3748), Chicago
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
In reclutamentoFase 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
In reclutamentoFase 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Dime La VerDAD: Verify, Debunk, and Disseminate
In reclutamentoVolontari sani benvenuti
- University of Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
In reclutamentoFase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Cognitive-Sensorimotor Function in Long-COVID
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Dysbiosis & Long COVID
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- The University of Chicago, Chicago
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
In reclutamentoFase 4Volontari sani benvenuti
- University of Chicago, Chicago
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
In reclutamentoFase 3
- University of Chicago Medical Center, Chicago
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
In reclutamentoFase 3
- University of Illinois Health, Chicago
Convalescent Plasma as a Possible Treatment for COVID-19
In reclutamentoFase 2
- University of Illinois at Chicago, Chicago
Studi su Condizioni post-COVID (Long COVID) in altre città
- New York City, NY15 studi
- Houston, TX13 studi
- Boston, MA13 studi
- Baltimore, MD12 studi
- Washington, DC10 studi
- San Francisco, CA8 studi
- Durham, NC8 studi
- Atlanta, GA8 studi
- San Diego, CA7 studi
- Los Angeles, CA6 studi
- Pittsburgh, PA6 studi
- Hialeah, FL6 studi
Altri studi a Chicago
- Cancro del polmone non a piccole cellule61 studi
- Cancro al seno59 studi
- Cancro (tutti i tipi)51 studi
- Cancro metastatico45 studi
- Cancro alla prostata45 studi
- Cancro ai polmoni41 studi
- Obesità41 studi
- Cancro ovarico36 studi
- Cancro colorettale34 studi
- Ictus34 studi
- Insufficienza cardiaca31 studi
- Sovrappeso29 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.